Generic Drug Devices Focus Group
Moderator Guide
Updated 11/18/2021
Introduction and Ground Rules
When moderator admits each participant, one by one, to the focus group, they will check to make sure that they have their sealed envelope next to them and that it hasn’t been opened. If someone doesn’t have their envelope, they will be told they are not able to participate in the focus group. If someone has opened their envelope, the moderator will make a note of that and will either replace that participant with one of the extras (if possible) or will admit the participant.
MODERATOR:
Welcome and thank you for participating in tonight’s discussion. My name is _________________, and I work for RTI International, a non-profit research organization. You have been asked to be part of tonight’s discussion, because you said that [you/your family member] use an autoinjector prescription drug device. The Food and Drug Administration (FDA) is interested in hearing your opinions about and experiences with the autoinjector medicine that [you use/your family member] uses.
We’re interested in hearing from you all today about your experiences and opinions. I’m not a medical professional or an expert on the topics we will discuss. My role is only to moderate today’s focus group and make sure that everyone has the chance to express their ideas and opinions.
Review ground rules:
I want to go over a few ground rules for our discussion tonight. Our discussion will last about 90 minutes, and your participation is voluntary. You have the right to not answer any question or withdraw from the study at any time.
If at any time you are uncomfortable with my questions, you can choose not to answer.
If you are unclear about what I am asking, please do not hesitate to ask me to repeat the question or provide clarification.
Since we are using Zoom for tonight’s discussion, I want to point out two features that we’ll be using:
At the beginning I will ask some questions using the Poll feature. I will tell you when that happens, and a poll will appear on the screen. When the question and answers appear on the screen, I’d like you to answer the question. I won’t be sharing the results. Your responses will only be seen by me and the RTI team; no one else in the group will see your responses.
I will ask you some question using the Chat feature, which is located at the bottom of the screen. I will provide more details when we use the chat, but I wanted to let you know that your responses will only be seen by me and the RTI team.
Everything we discuss today will be kept private to the extent permitted by law. Use only your first name or a nickname in the group. Only the recruiters have your full name and contact information. This information will not be given to anyone at RTI or to anyone at FDA, and no one will contact you after this discussion is over.
We ask that participants not audio record or share anything that we discuss today with anyone outside of the group. If you are speaking about someone else, please do not share their name or other identifying information.
Our discussion will be audio and video recorded by the RTI team. The recordings will be transcribed and will help me write the final report summarizing the feedback from the various focus groups being conducted. The recordings and transcripts will be stored on password-protected computers at RTI and FDA. No names or identifying information will be included in the transcripts or mentioned in the final report created from these focus group discussions.
Some members of the research team from RTI and FDA are joining the focus group virtually, but you won’t see or hear them. They want to hear your opinions and experiences directly from you and make sure that I ask you all the questions I have for you. Near the end of our conversation, I’m going to check the chat to see if they have any last-minute questions for me to ask you.
Please try to speak one at a time. I may occasionally interrupt when two or more people are talking at the same time to be sure everyone gets a chance to talk and that responses are accurately recorded. To help make sure everyone gets the chance to talk and to avoid having people talk over each other, I may call on people individually. If you are comfortable with it, you can also use the “hand raise” feature in Zoom to show that you would like to respond. You can either answer when called upon or feel free to say “pass” if you don’t wish to answer.
[FOR ADOLESCENTS] None of the answers you give will be shared with your parent or guardian. I would like us to keep what’s said here in the group private, so please don’t talk to anyone outside of this group about what we’ve discussed.
Please make sure your video is enabled and minimize any distractions for the next 90 minutes. If you could put your phones away and make sure you are in a place where you can hear and be heard without too much background noise, I would appreciate it.
Do you have any questions before we begin?
|
First, I’d like to go around our Zoom room and introduce ourselves. I will call on people in the order that I see you on my screen. When we get to you, please let us know your first name or your nick name and one thing you’d be doing if you weren’t here [today/tonight] |
|
|
First, I’d like to start today’s discussion by talking about your experiences with your current autoinjector medicine. We are going to start with a couple of poll questions. Let me know if you don’t see the first poll question on your screen. As a reminder, these responses are confidential and no one else in the group will see your responses. |
|
Poll Question #1: How long [have you/has your family member] been using an autoinjector?
[MODERATOR to allow 1-2 minutes to answer the poll before announcing the next question.] |
|
Poll Question #1a (Caregivers only): Which family member of yours uses an autoinjector?
[MODERATOR to allow 1-2 minutes to answer the poll before announcing the next question.] |
|
Poll Question #2: How satisfied or dissatisfied are you with [your/your family member’s] current autoinjector?
|
|
What do you wish someone had told you about the AI before using it for the first time? |
|
I am going to show you two more questions that will appear as a “poll” on your screen. |
|
Poll Question #3: Did you get training on administering the medication when [you/your family member] was first prescribed an autoinjector, even if it is different than the one [you/they] have now?
[MODERATOR to allow 1-2 minutes to answer the poll before announcing the next question.] |
|
Poll Question #4: If you got training, who gave it to you?
[MODERATOR to allow 1-2 minutes to answer the poll before announcing the next question.] |
|
How long did it take before you were comfortable using [your/your family member’s] AI? What were the hardest parts to learn? |
|
Is there anyone in the group who did not receive training about how to use their auto-injector medicine before using it for the first time? (If yes, continue to bulleted question)
If you hadn’t gotten training on the AI, where would you have looked for information? |
|
What else would you have wanted to know? |
|
|
|
You’re all here tonight, because you reported that [you use/you are a caregiver for someone who uses] some sort of Auto-injector. First, I’d like to hear your thoughts about generic drugs. Before we start, I’d like to start with an exercise to get us thinking about what these products are. I’m going to show you a question on the screen. [Moderator will click “share screen” and share a word document that says “What are some words, thoughts or feelings that come to mind when you hear the term ‘generic drug’”] |
|
[MODERATOR/NOTETAKER WILL WRITE A PROMPT (E.G., “GENERIC DRUG: THOUGHTS”) IN THE CHAT] What does “generic drug” mean to you? Please type your response using the chat feature. Your responses in the chat will go directly to me and my colleague [insert name]. We are the only one who can see your responses. |
|
[MODERATOR GIVE PARTICIPANTS TIME TO TYPE RESPONSES IN CHAT ] |
|
Who would like to share what they typed in the chat? [MODERATOR ORALLY SHARE ANONYMIZED RESPONSES WITH THE GROUP TO PROMPT DISCUSSION] |
|
Let’s talk briefly about your responses. [MODERATOR NOTE SIMILARITIES/DIFFERENCES ACROSS RESPONSES] |
|
Why did these words come to mind?
|
|
What do you think would be different if your current AI was replaced by a generic version? If your AI has been replaced by a generic version in the past, what differences did you experience? |
|
|
|
[MODERATOR CONFIRMS THAT PARTICIPANTS HAVE HAD A CHANCE TO REVIEW BRANDED AND GENERIC DEVICES] |
|
Now that you’ve seen the branded and generic device, what are your initial thoughts on how the generic device is similar or different from the branded AI? |
|
What kind of training, if any, would you want before you used the generic AI? |
|
[FALSE CLOSE] I’m going to check the chat to see if I forgot anything or if my colleagues have any last-minute questions before we finish up.
Closing
I would like to thank you for participating in this virtual focus group today. This research was sponsored by the Food and Drug Administration also known as the FDA. FDA would like to thank you for sharing your opinions, as they will be very useful in helping them understand people’s reactions and thoughts about the autoinjectors we talked about. Feel free to dispose of all the materials that we used today. Thank you!
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Coleman, Blair |
File Modified | 0000-00-00 |
File Created | 2022-07-11 |